| Literature DB >> 25193067 |
Abstract
Inhaled antibiotics dramatically improve targeting of drug to the site of respiratory infections, while simultaneously minimizing systemic exposure and associated toxicity. The high local concentrations of antibiotic may enable more effective treatment of multi-drug resistant pathogens. This review explores barriers to effective treatment with inhaled antibiotics. In addition, potential opportunities for improvements in treatment are reviewed.Entities:
Keywords: Biofilm; Dry powder inhaler; Endpoint; Fixed dose combination; Nebulizer; Partial liquid ventilation; Tolerability
Mesh:
Substances:
Year: 2014 PMID: 25193067 DOI: 10.1016/j.addr.2014.08.013
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN: 0169-409X Impact factor: 15.470